Johnson & Johnson Aktie
WKN: 853260 / ISIN: US4781601046
12.06.2018 22:19:22
|
Johnson & Johnson Accepts Platinum Equity's Offer To Buy LifeScan For $2.1 Bln
(RTTNews) - Johnson & Johnson (JNJ) Tuesday said it has accepted an offer from Platinum Equity to acquire its LifeScan business for about $2.1 billion.
LifeScan Inc. is popular for its blood glucose monitoring products, including the OneTouch brand of products, with 2017 net revenue of around $1.5 billion.
On March 16, Johnson & Johnson received an offer from Platinum Equity, a private investment firm, to buy its LifeScan business for about $2.1 billion
"This acceptance was made after consultation with relevant works councils and trade unions," JNJ said in a statement.
The transaction is expected to close by the end of 2018, subject to the satisfaction of regulatory clearances and other customary closing conditions.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
04.06.25 |
Freundlicher Handel: Dow Jones mittags freundlich (finanzen.at) | |
04.06.25 |
Börse New York in Grün: Dow Jones zum Handelsstart freundlich (finanzen.at) | |
03.06.25 |
Börse New York: Letztendlich Gewinne im Dow Jones (finanzen.at) | |
03.06.25 |
Börse New York: Dow Jones nachmittags im Aufwind (finanzen.at) | |
02.06.25 |
Dow Jones aktuell: Dow Jones verbucht zum Start des Montagshandels Abschläge (finanzen.at) | |
30.05.25 |
Börse New York in Grün: Dow Jones beendet den Freitagshandel in der Gewinnzone (finanzen.at) | |
30.05.25 |
Handel in New York: Dow Jones beginnt die Sitzung im Minus (finanzen.at) | |
29.05.25 |
Freundlicher Handel in New York: Dow Jones notiert zum Handelsende im Plus (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 134,60 | -1,03% |
|